Innovexon Nexara™
Frequently Asked Questions
Innovexon Nexara is a software platform built specifically for AI buyers, investors, auditors, and insurers. Innovexon Nexara helps buyers, investors, auditors, and insurers evaluate AI technology before money is spent, harmful risks are accepted, or insurance policies are issued.
The people who carry the consequences of an AI decision: buyers and operators adopting AI, investors and capital allocators funding it, auditors and compliance teams reviewing it, and insurers and underwriters pricing its risk — along with the strategic partners who bring Innovexon Nexara to the clients they serve.
Today, vendors are promising their customers value that is unsupported by the technology; AI-related litigation is increasing, and organizations lack a tool that helps them, in a standard, repeatable way, determine whether an AI deployment would produce value, benefits, risks, or something else. Innovexon Nexara was built to equip decision-makers with a tool that lets them know whether an AI deployment would help or harm their organization before money is spent or risk is taken.
Innovexon Nexara conducts three separate evaluations:
- Investment — for organizations evaluating whether to buy, adopt, fund, deploy, replace, or rely on AI technology.
- Audit — for organizations that need to review an AI decision, reconstruct what was known or knowable from the record, evaluate whether an in-use AI system is delivering the value promised, or understand whether the decision can be defended later.
- Underwriting — for insurers and underwriters that need to translate AI-specific risk into insurer-native terms, including expected loss, premium posture, reserve support, coverage position, and pre-bind conditions.
All Innovexon Nexara evaluations produce decision-ready recommendations that you can act on when you need to act. While deliverables are tailored to each Innovexon customer, all Innovexon Nexara recommendations help organizations answer the question: Are the value claims or projections credible? What is the likely payback? Does the AI deployment carry more risk than value? Should an insurer insure your operational outputs? And every evaluation is shaped by your industry, sector, regulatory environment, and role.
Many tools organizations use to evaluate AI technology predate AI. Innovexon Nexara was built with AI in mind. In a unified platform, Innovexon Nexara lets customers determine, for example, if a 20% capture rate is possible with the current model; if sufficient failure containment strategies are in place, should data get corrupted or compromised in autonomous driving cars; or how many people or facilities could be harmed if a model fails. Innovexon Nexara is guided by the decisions, and not a checklist. See a quick comparison of Innovexon Nexara against existing tools:
| Your decision | How are these decisions made today? | Innovexon Nexara |
|---|---|---|
| Should we invest in an AI company, or buy a particular AI model? | Customers release RFPs, receive vendor questionnaires, ROI models, and diligence checklists — built to compare vendors and estimate return, not to test whether the promised value is real once you account for the risk. | Innovexon Nexara is a software platform that guides each user through industry and use-case informed workflows that independently determine value, risk, and produce a recommendation. Innovexon Nexara ingests and extracts information from customer-supplied information. |
| Is the AI we already use delivering the value we were promised — and if it failed, could we defend the decision? | Audit workpapers, evidence requests, and GRC exports — built to document that a review happened, often reconstructed after the fact from whatever records exist | Innovexon Nexara reconstructs the AI’s environment and decision record — what was known, what should have been known, and what was foreseeable — and determines whether an in-use system is delivering the value it promised, so the decision can be explained and defended later. |
| Can we underwrite this AI system’s risk, and on what terms? | Underwriting questionnaires and actuarial and rating tools — built to collect risk facts and price familiar exposures, not AI-specific ones | Without needing to “speak AI,” Innovexon Nexara translates AI-specific risks and liabilities into insurer-native terms — expected loss, capital reserve, premium posture, reserve support, and the conditions required before binding. |
No. Governance, GRC, and procurement tools can support parts of the AI review process. They can help organizations track controls, collect vendor responses, manage approvals, store records, or document review activity.
Innovexon Nexara was built for the AI evaluation itself. It brings value, risk, governance, evidence, assumptions, liability, auditability, and insurability into a software-implemented workflow for Investment, Audit, and Underwriting evaluations.
Innovexon Nexara uses a proprietary evaluation method to assess AI-delivered value and risk.
The platform guides the user through a role-specific workflow, collects and organizes relevant information, evaluates the claims and assumptions behind the AI decision, identifies gaps or unresolved issues, and produces outputs designed to support an Investment, Audit, or Underwriting decision.
It does not make the decision for the user. It gives the user a structured record for making, reviewing, or defending that decision.
Innovexon Nexara was built by a decision-maker for decision-makers that carry real consequences.
Innovexon was founded by a former Chief Executive of a $100M+ technology and data enterprise and former cybersecurity regulator who, across nearly 30 years, has led a $13 billion real estate portfolio and a nearly $100 million economic development organization.
The platform reflects that perspective: AI is not only a technical decision. It is a value, risk, governance, liability, audit, underwriting, and executive judgment decision.
Yes. Innovexon Nexara is sector-informed and industry-adaptable. AI value and risk do not look the same across sectors. A healthcare deployment, financial services model, insurance workflow, logistics platform, autonomous system, public-sector use case, or enterprise software purchase may raise different questions.
Innovexon Nexara shapes the evaluation around the customer’s role, industry, use case, operating environment, and decision type.
A guided, limited-access program for selected organizations — not open sign-up, a free trial, or an open beta. It’s how Innovexon Nexara is being introduced to a small number of buyers, investors, auditors, insurers, and partners ahead of broader availability.
A limited number of live demonstrations are being offered to selected organizations ahead of restricted access. To request a demo, please click the Request Demo or email us at demos@innovexon.io.
Restricted access begins later this year, with broader availability to follow.
Pricing depends on the evaluation type, scope, and engagement structure. For pricing information, contact sales@innovexon.io.